Alpha Cognition, Inc. (ACOG)
8.20
+0.05
(+0.61%)
USD |
NASDAQ |
Nov 06, 10:01
Alpha Cognition Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.022 |
| September 30, 2024 | -1.243 |
| June 30, 2024 | -0.8694 |
| March 31, 2024 | 6.552 |
| December 31, 2023 | -0.259 |
| September 30, 2023 | -0.1884 |
| June 30, 2023 | -2.424 |
| March 31, 2023 | 0.8852 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.9177 |
| September 30, 2022 | 0.6623 |
| June 30, 2022 | 0.274 |
| March 31, 2022 | 0.1616 |
| December 31, 2021 | 0.1191 |
| September 30, 2021 | 0.7343 |
| March 31, 2021 | -0.7588 |
| January 31, 2021 | 0.00 |
| January 31, 2020 | 0.00 |
| October 31, 2019 | 0.00 |
| July 31, 2019 | 0.00 |
| April 30, 2019 | 0.00 |
| January 31, 2019 | 0.00 |
| October 31, 2018 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0413 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 64.52M |
| Total Liabilities (Quarterly) | 11.56M |
| Shareholders Equity (Quarterly) | 52.96M |
| Current Ratio | 8.998 |